Promising Thrombin Biomarkers For Identifying High-Risk VTE Patients – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Geke C. Poolen et al, adding:
”Thrombin Generation and Thrombin Dynamics Are Associated with Recurrent Venous Thromboembolism After Anticoagulation Withdrawal
In 589 VTE patients, reduced endogenous thrombin potential, thrombomodulin sensitivity, and thrombin inactivation by antithrombin were significantly associated with VTE recurrence after stopping anticoagulation, highlighting these parameters as promising biomarkers for identifying high-risk patients.”
Title: Thrombin generation and thrombin dynamics are associated with recurrent venous thromboembolism after anticoagulation withdrawal
Authors: Geke C. Poolen, Romy M.W. de Laat-Kremers, Mark Roest, Geert-Jan Geersing, Rolf T. Urbanus, Bas de Laat, Roger E.G. Schutgens
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?